Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | N/A | NA4452 | IM / RA |
On the morning of September 30, 2025, the patient received a dose of the Cominarty (Pfizer-BioNTech) COVID-19 vaccine during a vaccine clinic held at her assisted living facility. The patient had requested the vaccine and did not recall having already received a dose earlier in the month. It was later discovered that the patient had previously received a Cominarty COVID-19 vaccine at her primary care provider's office on September 7, 2025. Due to the patient's mild dementia, she was unable to recall the earlier vaccineation, and a second dose was inadvertently administered within the same month. Following the administration of the second dose, the patient did reported feeling mildly feverish. However, multiple temperature checks revealed no measurable fever, and the patient remained clinically stable. Per nursing staff at nursing home, the patient did not exhibit any severe symptoms and continues to do well. This report is being submitted out of an abundance of caution due to the administration of an additional dose within a short interval.
none
Dementia
none
none
None